{"AAPL": {"Ticker": "AAPL", "Company": "Apple", "Sector": "Information Technology", "Updated": "2023-03-06", "Rating": [{"Date": "2023-03-06", "Rating": "Initiated", "Organization": "Goldman", "Rating_Change": "Buy", "Target_Change": "$199"}, {"Date": "2023-03-03", "Rating": "Reiterated", "Organization": "Morgan Stanley", "Rating_Change": "Overweight", "Target_Change": "$175 to $180"}, {"Date": "2023-01-27", "Rating": "Reiterated", "Organization": "BofA Securities", "Rating_Change": "Neutral", "Target_Change": "$154 to $153"}, {"Date": "2023-01-23", "Rating": "Reiterated", "Organization": "Deutsche Bank", "Rating_Change": "Buy", "Target_Change": "$170 to $160"}, {"Date": "2023-01-18", "Rating": "Reiterated", "Organization": "Canaccord Genuity", "Rating_Change": "Buy", "Target_Change": "$200 to $170"}, {"Date": "2023-01-03", "Rating": "Downgrade", "Organization": "Exane BNP Paribas", "Rating_Change": "Outperform to Neutral", "Target_Change": "$140"}, {"Date": "2022-12-20", "Rating": "Reiterated", "Organization": "JP Morgan", "Rating_Change": "Overweight", "Target_Change": "$200 to $190"}, {"Date": "2022-12-12", "Rating": "Reiterated", "Organization": "Oppenheimer", "Rating_Change": "Outperform", "Target_Change": "$190 to $170"}], "Score": 1.25, "Cumulative_Rating": "Outperform", "Number_of_Analysts": 8, "Period": "180 days", "Letter_Rating": "B", "Analists": ["Deutsche Bank", "Exane BNP Paribas", "Morgan Stanley", "Oppenheimer", "Goldman", "Canaccord Genuity", "BofA Securities", "JP Morgan"], "Price_Target": 170.25}, "BMY": {"Ticker": "BMY", "Company": "Bristol Myers Squibb", "Sector": "Health Care", "Updated": "2023-03-06", "Rating": [{"Date": "2023-03-06", "Rating": "Initiated", "Organization": "Jefferies", "Rating_Change": "Hold", "Target_Change": "$62"}, {"Date": "2023-01-17", "Rating": "Initiated", "Organization": "Cantor Fitzgerald", "Rating_Change": "Overweight", "Target_Change": "$95"}], "Score": 1.0, "Cumulative_Rating": "Outperform", "Number_of_Analysts": 2, "Period": "180 days", "Letter_Rating": "B", "Analists": ["Jefferies", "Cantor Fitzgerald"], "Price_Target": 78.5}, "DHI": {"Ticker": "DHI", "Company": "D. R. Horton", "Sector": "Consumer Discretionary", "Updated": "2023-03-06", "Rating": [{"Date": "2023-03-06", "Rating": "Downgrade", "Organization": "JP Morgan", "Rating_Change": "Overweight to Neutral", "Target_Change": "$107 to $102.50"}, {"Date": "2023-01-25", "Rating": "Downgrade", "Organization": "Wedbush", "Rating_Change": "Outperform to Neutral", "Target_Change": "$104 to $96"}, {"Date": "2023-01-19", "Rating": "Initiated", "Organization": "Oppenheimer", "Rating_Change": "Perform", "Target_Change": ""}, {"Date": "2023-01-13", "Rating": "Downgrade", "Organization": "RBC Capital Mkts", "Rating_Change": "Sector Perform to Underperform", "Target_Change": "$68 to $76"}, {"Date": "2023-01-09", "Rating": "Downgrade", "Organization": "Raymond James", "Rating_Change": "Outperform to Mkt Perform", "Target_Change": ""}], "Score": -1.2, "Cumulative_Rating": "Underperform", "Number_of_Analysts": 5, "Period": "180 days", "Letter_Rating": "D", "Analists": ["Raymond James", "Oppenheimer", "Wedbush", "RBC Capital Mkts", "JP Morgan"], "Price_Target": 86.0}, "LLY": {"Ticker": "LLY", "Company": "Eli Lilly & Co", "Sector": "Health Care", "Updated": "2023-03-06", "Rating": [{"Date": "2023-03-06", "Rating": "Initiated", "Organization": "Jefferies", "Rating_Change": "Hold", "Target_Change": "$290"}, {"Date": "2023-02-15", "Rating": "Downgrade", "Organization": "Societe Generale", "Rating_Change": "Hold to Sell", "Target_Change": ""}], "Score": -1.0, "Cumulative_Rating": "Underperform", "Number_of_Analysts": 2, "Period": "180 days", "Letter_Rating": "D", "Analists": ["Societe Generale", "Jefferies"], "Price_Target": 290.0}, "EMR": {"Ticker": "EMR", "Company": "Emerson Electric Company", "Sector": "Industrials", "Updated": "2023-03-06", "Rating": [{"Date": "2023-03-06", "Rating": "Upgrade", "Organization": "UBS", "Rating_Change": "Neutral to Buy", "Target_Change": "$100 to $97"}, {"Date": "2023-02-14", "Rating": "Downgrade", "Organization": "Argus", "Rating_Change": "Buy to Hold", "Target_Change": ""}, {"Date": "2023-01-04", "Rating": "Downgrade", "Organization": "UBS", "Rating_Change": "Buy to Neutral", "Target_Change": "$118 to $100"}], "Score": 0.0, "Cumulative_Rating": "Neutral", "Number_of_Analysts": 3, "Period": "180 days", "Letter_Rating": "C", "Analists": ["UBS", "Argus"], "Price_Target": 98.5}, "GE": {"Ticker": "GE", "Company": "General Electric", "Sector": "Industrials", "Updated": "2023-03-06", "Rating": [{"Date": "2023-03-06", "Rating": "Resumed", "Organization": "JP Morgan", "Rating_Change": "Neutral", "Target_Change": "$88"}, {"Date": "2022-12-09", "Rating": "Reiterated", "Organization": "RBC Capital Mkts", "Rating_Change": "Outperform", "Target_Change": "$93 to $98"}], "Score": 1.0, "Cumulative_Rating": "Outperform", "Number_of_Analysts": 2, "Period": "180 days", "Letter_Rating": "B", "Analists": ["RBC Capital Mkts", "JP Morgan"], "Price_Target": 93.0}, "MRK": {"Ticker": "MRK", "Company": "Merck & Co.", "Sector": "Health Care", "Updated": "2023-03-06", "Rating": [{"Date": "2023-03-06", "Rating": "Initiated", "Organization": "Jefferies", "Rating_Change": "Buy", "Target_Change": "$125"}, {"Date": "2023-02-22", "Rating": "Upgrade", "Organization": "Wolfe Research", "Rating_Change": "Peer Perform to Outperform", "Target_Change": "$127"}, {"Date": "2023-01-04", "Rating": "Upgrade", "Organization": "BofA Securities", "Rating_Change": "Neutral to Buy", "Target_Change": "$110 to $130"}], "Score": 2.0, "Cumulative_Rating": "Significant Outperform", "Number_of_Analysts": 3, "Period": "180 days", "Letter_Rating": "A", "Analists": ["Wolfe Research", "Jefferies", "BofA Securities"], "Price_Target": 127.33}, "MNST": {"Ticker": "MNST", "Company": "Monster Beverage", "Sector": "Consumer Staples", "Updated": "2023-03-06", "Rating": [{"Date": "2023-03-06", "Rating": "Upgrade", "Organization": "Redburn", "Rating_Change": "Neutral to Buy", "Target_Change": "$120"}, {"Date": "2023-03-01", "Rating": "Reiterated", "Organization": "Wells Fargo", "Rating_Change": "Overweight", "Target_Change": "$115 to $113"}, {"Date": "2023-03-01", "Rating": "Reiterated", "Organization": "Truist", "Rating_Change": "Buy", "Target_Change": "$100 to $120"}, {"Date": "2023-03-01", "Rating": "Reiterated", "Organization": "Morgan Stanley", "Rating_Change": "Overweight", "Target_Change": "$117 to $115"}, {"Date": "2023-03-01", "Rating": "Reiterated", "Organization": "JP Morgan", "Rating_Change": "Overweight", "Target_Change": "$114 to $112"}, {"Date": "2023-03-01", "Rating": "Reiterated", "Organization": "Citigroup", "Rating_Change": "Buy", "Target_Change": "$121 to $118"}, {"Date": "2023-03-01", "Rating": "Reiterated", "Organization": "BMO Capital Markets", "Rating_Change": "Market Perform", "Target_Change": "$97 to $105"}, {"Date": "2023-03-01", "Rating": "Downgrade", "Organization": "CFRA", "Rating_Change": "Buy to Hold", "Target_Change": "$110 to $100"}, {"Date": "2023-02-17", "Rating": "Initiated", "Organization": "Citigroup", "Rating_Change": "Buy", "Target_Change": "$121"}, {"Date": "2023-01-18", "Rating": "Reiterated", "Organization": "Evercore ISI", "Rating_Change": "Outperform", "Target_Change": "$105 to $115"}, {"Date": "2023-01-18", "Rating": "Reiterated", "Organization": "BMO Capital Markets", "Rating_Change": "Market Perform", "Target_Change": "$95 to $97"}], "Score": 1.36, "Cumulative_Rating": "Outperform", "Number_of_Analysts": 11, "Period": "180 days", "Letter_Rating": "B", "Analists": ["Morgan Stanley", "CFRA", "Truist", "BMO Capital Markets", "Redburn", "Evercore ISI", "Citigroup", "JP Morgan", "Wells Fargo"], "Price_Target": 112.36}, "PFE": {"Ticker": "PFE", "Company": "Pfizer", "Sector": "Health Care", "Updated": "2023-03-06", "Rating": [{"Date": "2023-03-06", "Rating": "Initiated", "Organization": "Jefferies", "Rating_Change": "Hold", "Target_Change": "$43"}, {"Date": "2023-02-07", "Rating": "Upgrade", "Organization": "Daiwa Securities", "Rating_Change": "Neutral to Outperform", "Target_Change": "$51"}, {"Date": "2023-01-26", "Rating": "Downgrade", "Organization": "UBS", "Rating_Change": "Buy to Neutral", "Target_Change": "$55 to $47"}, {"Date": "2023-01-17", "Rating": "Downgrade", "Organization": "Wells Fargo", "Rating_Change": "Overweight to Equal Weight", "Target_Change": "$54 to $50"}, {"Date": "2023-01-04", "Rating": "Downgrade", "Organization": "BofA Securities", "Rating_Change": "Buy to Neutral", "Target_Change": "$60"}, {"Date": "2022-12-13", "Rating": "Upgrade", "Organization": "Goldman", "Rating_Change": "Neutral to Buy", "Target_Change": "$47 to $60"}], "Score": 0.0, "Cumulative_Rating": "Neutral", "Number_of_Analysts": 6, "Period": "180 days", "Letter_Rating": "C", "Analists": ["Jefferies", "Goldman", "Daiwa Securities", "BofA Securities", "UBS", "Wells Fargo"], "Price_Target": 51.83}}